We recently published a list of the 13 Most Undervalued Blue Chip Stocks To Buy According To Analysts. In this article, we ...

The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Keytruda shows promise as a first line option in cervical cancer cutting patients' mortality risk by a third in a Phase 3 ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $117.96 which represents a slight increase of $2.10 or 1.81% from the prior close of $115.86. The stock opened at $115.8 and touched a ...

Merck (MRK) and Daiichi Sankyo (DSNKY) announce early results from a Phase 2 trial of lung cancer drug I-DXd, an antibody ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $115.25 which represents a slight increase of $0.54 or 0.47% from the prior close of $114.71. The stock opened at $114.47 and touched ...

Jefferies analyst Akash Tewari maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...

As of 20 September at 1:40 pm GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

As of 19 September at 9:54 am GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.